Series A - Sudo Biosciences
Investment Firm
Overview
Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.
Announced Date
Sep 28, 2022
Funding Type
Series A
Highlights
Location
United States, North America
Social
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Sudo Biosciences raised $37000000 on 2022-09-28 in Series A
Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Sep 28, 2022 |  Series A - Sudo Biosciences | 2 | - | 37.0M |
| Dec 20, 2023 | Series B - Sudo Biosciences | 9 | - | 116.0M |
| Feb 13, 2024 | Series B - Sudo Biosciences | 11 | - | 30.0M |
Recent Activity
There is no recent news or activity for this profile.